Blog


Endo International Settles Securities Settlement for $82.5 Million

Second Endo Settlement of 2019



Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”

So what’s the difference? Aside from $32.5 million.

The first settlement pertained to declining demand for Endo’s generic drugs and also alleged that Endo had conspired to fix prices, which resulted in inflated stock and later a law enforcement inquiry. Once the scheme collapsed, plaintiffs alleged, the stock price collapsed with it.

This newer settlement pertains to Endo’s role in the opioid crisis. Specifically, plaintiffs allege that “failed to disclose material adverse facts regarding the putative safety and abuse-deterrent properties of Reformulated Opana, an opioid analgesic indicated for the management of severe pain that requires daily opioid treatment.”

Here are the other key facts:

Case name: Endo International

Settlement fund: $82,500,000

Claim filing deadline: 2/7/2020

Class period: 11/30/2012 – 6/8/2017

Definition of class from settlement notice:

“All persons and entities who purchased or otherwise acquired Endo common stock or ordinary shares between November 30, 2012 and June 8, 2017, inclusive, and were damaged thereby.”

Fairness Hearing: 12/11/2019

Exclusion Deadline: 11/22/2019

Objection Deadline: 11/22/2019

How Chicago Clearing Can Help: Every day, our team files claims in a wide assortment of financial class action litigations. We are preparing claims now for potential Endo International Class members… in both settlements! If you or your clients are eligible for this litigation, or any of the other 35 settlements with upcoming deadlines, then please give us a call at 312-204-6970.


More News from the Class Action World



Did you trade debt securities of government sponsored enterprises (aka GSE bonds) between 2009 and 2019? If so, you may be eligible to participate in an antitrust settlement.

Plaintiffs allege that the defendants (see full list below) conspired to fix prices of unsecured GSE bonds issued by Federal ... Read More

Case Name: Akorn 2019 Securities Settlement

Settlement Fund: Between $53.6 million and $155.4 Million

Claim Filing Deadline: January 24, 2020

Class Period: 11/3/2016 – 1/8/2019

Read More

Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”

So what’s the difference? Aside from $32.5 million.

The first settlement pertained to declining demand for Endo’s generic drugs and also alleged th... Read More

Investors in American Realty Capital Properties (ARCP), now known as Vereit, may be eligible for a massive settlement that could pay as much as 50% of damages. Given that the typical recovery is just 2%, this is great news for harmed ARCP investors.

What is this case about?

ARCP was an investment services firm fou... Read More

Case name: Puma Biotechnology

Verdict award: Up to $4.50 per damaged share, total award TBD

Claim filing deadline: 1/28/2020

Class period: 7/22/2014 – 5/29/2015

 

This week saw the rarest of rarities, a veritable solar eclipse o... Read More

Case name: SanDisk LLC Securities Litigation

Settlement fund: $50,000,000

Claim filing deadline: 9/12/2019

Class period: 10/16/2014 – 4/15/2015

Definition of class from settlement notice: “If you purchased or otherwise a... Read More